Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-06-05

Clinical Trial Update: Retarded Phosphatidylcholine in Steroid-Dependent Chronic Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating retarded phosphatidylcholine in steroid-dependent chronic active ulcerative colitis has completed. The sponsor listed is Heidelberg Uni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Retarded Phosphatidylcholine (phosphatidylcholine (retarded-release formulation))

Snippet

Sponsor: Heidelberg University | Conditions: Ulcerative Colitis, Phosphatidylcholine | Phase 2 | Status: COMPLETED